Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,Cystic Fibrosis Knowledge Centre

    Launch of the Cystic Fibrosis Knowledge Centre

    This new resource has been developed to support healthcare professionals
    in the treatment of patients with cystic fibrosis (CF).
    It contains a host of clinical information including a disease awareness section,
    emerging and supportive therapeutic options and current best practice
    based on recently updated guidelines by the
    European Cystic Fibrosis Society (ECFS).

  • ,CLL What's New

    New case-based chronic lymphocytic leukaemia
    CME module

    A new CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been
    added to the CLL Knowledge Centre on epgonline.org. Read case studies and improve
    your knowledge of CLL by answering quiz questions based on a variety of scenarios. This
    module has been EACCME-accredited and is worth 1 European CME credit. There is
    no cost to complete this educational activity.

  • ,Hypogonadism Relaunch Whats New

    Launch of updated Hypogonadism Knowledge Centre

    Our Hypogonadism Knowledge Centre contains important disease awareness
    information to support healthcare professionals in the current best practice
    treatment and management of male hypogonadism and is available to access free of
    charge. Sections cover epidemiology, pathophysiology, signs and symptoms, treatment
    options, as well as useful resources and a regularly updated publications digest.


  • ,

    New Type 2 Diabetes CME now available

    A new CME activity ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in
    Combination with Insulin’ has been added to the Type 2 Diabetes Learning Zone.
    Complete the five modules to enhance your understanding of the combination
    therapies available for treating type 2 diabetes.

  • ,COPD whats new ATS 2015

    ATS 2015 symposium materials added to
    COPD Knowledge Centre

    Speaker slides and a video from the Novartis-sponsored symposium ‘Are we gaining the
    maximum benefit from bronchodilators in COPD?’ have been added to the COPD Knowledge
    Centre. The session was held at the American Thoracic Society (ATS) conference 2015 to
    highlight the fundamental role of bronchodilators in COPD management, and presented
    key drug data including efficacy and safety of some of the latest COPD therapies.

Latest News

Data from phase III ENERGITO study of Stiolto Respimat (olodaterol + tiotropium) published in journal of chronic obstructive pulmonary disease- Boehringer


Boehringer has announced the publication of data that show Stiolto Respimat (olodaterol + tiotropium) improved lung function across a range of measures (FEV1 AUC0–12, FEV1 AUC0–24, FEV1 AUC12–24, peak0-3 FEV1 and trough FEV1) in patients with chronic ...

NICE now recommends Repatha (evolocumab) for dyslipidaemia-Amgen


The National Institute for Health and Care Excellence (NICE) has changed its mind regarding Repatha (evolocumab) from Amgen. In a new appraisal NICE accepts Repatha alone or in combination with other lipid lowering therapies at a dosage of 140 mg ...

NICE does not recommend Praluent (alirocumab) to treat high cholesterol-Sanofi


The National Institute for Health and Care Excellence has issued draft guidance not recommending Praluent (alirocumab)from Sanofi,for people with high cholesterol (primary hypercholesterolaemia - heterozygous-familial and non-familial) and mixed ...

FDA issues Complete Response Letter relating to Kalydeco (ivacaftor) treatment of residal function mutations of Cystic Fibrosis transmembrane conductance regulator (CFTR). -Vertex


Vertex Pharmaceuticals Incorporated announced that it received a Complete Response Letter from the FDA for its supplemental New Drug Application (sNDA) for the use of Kalydeco (ivacaftor) in people with cystic fibrosis (CF) ages 2 and older who have ...

Label update for Rexulti (brexpiprazole) filed with FDA for the maintenance treatment of adults with schizophrenia- Lundbeck and Otsuka


The FDA has accepted for review a supplemental New Drug Application (sNDA) for the proposed labeling update of Rexulti (brexpiprazole), from Lundbeck and Otsuka, for the maintenance treatment of adults with schizophrenia. Under the Prescription Drug ...

Abbott Laboratories acquires Kalila Medical and with it the Vado steerable sheath


Abbott Laboratories, a healthcare company, has acquired Kalila Medical, Inc., a developer of next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation. ...

Launch of new Cystic Fibrosis Knowledge Centre


​ A Cystic Fibrosis Knowledge Centre has launched on epgonline.org to support healthcare professionals in the treatment of patients with cystic fibrosis (CF). This resource contains a host of clinical information including a disease awareness ...

Recent Updates


Clinical Guidelines

Care of dying adults in the last days of life

Intravenous fluid therapy in children and young people in hospital

Type 2 diabetes: The management of type 2 diabetes

Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care

Medical Journals


Imatinib: a breakthrough of targeted therapy in cancer.

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Dulaglutide (LY-2189265) for the treatment of type 2 diabetes.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors